Fixation Free Sandwich Osteotomy With an Interpositional Inlay Graft in Compere to Conventional S… (NCT06089928) | Clinical Trial Compass
UnknownNot Applicable
Fixation Free Sandwich Osteotomy With an Interpositional Inlay Graft in Compere to Conventional Sandwich Osteotomy
Egypt16 participantsStarted 2024-01-01
Plain-language summary
The atrophatic anterior maxilla present a considerable challenge for both surgical and prosthetic rehabilitation, as it may require bone augmentation to enable implant placement. The techniques proposed for vertical augmentation of the alveolar ridge include distraction osteogenesis, only grafting, and sandwich osteoplasty. Sandwich osteotomy is reported to provide more stable and predictable results with respect to the height of the alveolar ridge. The main advantage of osteotomy techniques that employ Interpositional bone grafts is reported to be the improved blood supply in the augmented region.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Both sex
* Adulte patient (18-60 y.)
* Highly motivated patient with good oral hygiene
* No systematic diseases or conditions known to alter bone healing.
* No local pathosis that may interfere with bone healing.
* No recent history of augmentation procedure at the same area.
* Criteria of the edentulous ridge:
* The anterior maxillary vertical dimension is minimum 10mm, measured from the crest of the ridge to the nasal floor.
* Horizontal ridge dimension remains normal; at least 6mm.
* The minimum number of the missing teeth is minimum 2 teeth and the maximum will be the six anteriors.
* There will be increased inter-arch space compared with the adjacent teeth.
Exclusion Criteria:
* uncontrolled Diabetes mellitus (DM)
* pregnancy
* uncontrolled local factors(periodontitis), or acute infection related to the aera.
* smoking: more than 20 cigarettes \\day
* intravenous bisphosphonate
* patients who had received radiation treatment in the head and neck region.
* previous bone augmentation in the site within 6 months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.